Log In
Print this Print this

Palux, alprostadil

  Manage Alerts
Collapse Summary General Information
Company Taisho Pharmaceutical Holdings Co. Ltd.
DescriptionProstaglandin E1 a peripheral vasodilator
Molecular Target Prostaglandin E1 (PGE1) receptor
Mechanism of ActionBeta lactamase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPeripheral vascular disease (PVD)
Indication DetailsTreat intermittent claudication caused by spinal cord stenosis (SCS); Treat peripheral vascular disease (PVD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today